Save the date
Diagnostics-4-Future Conference 2026
Datum
-
Adresse
Bodenseeforum Konstanz
Veranstalter
BioLago e.V. - Das Gesundheitsnetzwerk
Kontakt
Michael Statnik
Conference Manager
Project Manager Diagnostics
Tel.: +49(0) 7531 71409 12
E-Mail: michael.statnik(at)biolago.org
Die folgenden Informationen sind nur auf Englisch verfügbar
Visit us at Diagnostics-4-Future Conference 2026!
We will be exhibiting at the conference – feel free to visit our booth and have a chat with us.
We will announce our stand number shortly.
As a special bonus, we are able to offer a 10 percent off voucher for tickets to the conference.
If you are interested, contact us at zaengle(at)bio-pro.de.
Reasons for Attending
- Summary of medical needs and diagnostic trends
- Experts as on hand conversation partners 150-200 participants from Europe and beyond
- Partnering & Exhibition opportunities to present your solutions
- International exchange & matchmaking
Characteristics of the Conference
Expertise
Initiator is the international health network BioLAGO where companies, research institutions and clinics work together on new diagnostics. The conference emerged from the DiagNET project.
Medical need
The discussed matters are highly user-oriented (physicians, clinicians, laboratories, medical centers). Medical needs and compatibility with user processes (clinical routine) are key factors for the conference.
Patient focus
Especially, patient-oriented solutions regarding health-care in regional hospitals are addressed (e.g. point-of-care-testing).
Openness
The conference connects partners worldwide with the 4-country region around Lake Constance (Germany, Switzerland, Austria & Liechtenstein). Past conferences brought together experts from over 15 countries (Europe, USA, Asia).
Topics and program highlights 2026:
- Precision medicine & diagnostics
Victor Voicu, Clinic Hirslanden
Prof. Dr. Veronika Ruzsanyi, University of Innsbruck
Dr. Christoph Schröder, Sciomics GmbH
- Antimicrobial resistance, phage therapy & the need for future diagnostics
Dr. Shawna McCallin, Balgrist University Hospital
Mike Marquet, University Hospital Jena / nanozoo GmbH
Hendrik Koliwer-Brandl, Institute of Medical Microbiology, University of Zurich
- Diagnosing Cancer – novel approaches
Prof. Dr. med. Dr. phil. Torsten Haferlach, MLL Munich Leukemia Laboratory
Prof. Dr. med. Stefan Pfister, Hopp Children’s Cancer Center Heidelberg
- Prevention and the role of diagnostics
Dr. Dr. med. Saskia Biskup, CeGaT / Center for Human Genetics Tübingen
John Volke, Brightsens Diagnostics
Daniel Gillmann, RICB Diagnostics AG
